Kenvue Stock Soars Following $40 Billion Acquisition by Kimberly-Clark

Shares of Kenvue Inc. (NYSE: KVUE) skyrocketed in premarket trading on Monday, November 3, 2025, after news broke that Kimberly-Clark Corporation was acquiring the iconic Tylenol maker for a whopping $48.7 billion. This massive transaction marks one of the largest consumer goods sector buyouts ever undertaken and is expected to create a colossal health and personal care company with an estimated annual revenue exceeding $32 billion. Shareholders will receive a substantial $21.01 per share, representing a significant 46.2% premium over the stock’s closing price on October 31.